//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
@Drug_Science blog on the new Compass #psilocybin for #depression study drugscience.org.uk/compass-phase3
3mo
Psychiatric medicine is undergoing a seismic shift as Compass pathways announce successful results from its Phase 3 trial (COMP006).
From psychedelic trips to treating Treatment-Resistant Depression. The possible gamechanger COMP360
drugscience.org.uk